From the Author:
Q&A with Harry Glorikian
Congratulations on thepublication of your book, MoneyBall Medicine. What do you want your audience totake away from the book?
Thank you! The biggesttakeaway I'd like readers to have is that data and technology are alreadystarting to make big differences in patient care, drug development, and nearlyevery aspect of healthcare; but it's time to go from being something that justa few places are taking advantage of, to an industry where everyone is usingthem. When we have systems in place for collecting and analyzing the data, wecan use those insights to transform healthcare.
What inspired you, andyour co-author Malorye Allison Branca, to focus on the advances in healthinformation technology?
I've been in healthcarefor decades and had seen how technology transformed other industries, likebanking. We've moved from standing in line at a bank to taking a picture of acheck with my phone to make a deposit. That's a giant leap forward because ofthe technology, like ATMs and online banking, and because of the consumeradoption of and attitudes about the technologies.
I began to question whywe weren't seeing technology and data transform healthcare in the same way. Whycan't patients easily share their health information with doctors and hospitalsacross the country? How can doctors quickly determine which clinical trial apatient should enroll in--and then make it simple for the patient to do so? Whyis there still so much trial and error when it comes to picking the righttreatment for a patient? What can Pharma do to shorten the length of time ittakes to bring a drug to market and how can they make it less expensive andminimize the risks of failure? How can we diagnose patients with rare diseasesfaster? What can health systems do to streamline their processes and operationswhile improving patient care? I think the answers to these questions lies inleveraging technology and data.
Why is your book relevantto present and future healthcare professionals?
MoneyBall Medicine takesa look at the current state of how the industry is using data and technologyand then goes one step further--where can it take us if we embrace thetechnology instead of fighting it? The book also ties in the business aspectfor healthcare. I think it has broad appeal, not just to those who are alreadyin the field, but also to people who might come to healthcare from a strictlytech background. I think we'll start to see more of our future healthcareprofessionals come from different industries with skills we haven'ttraditionally associated with healthcare. I think this book can help them seewhere they fit into the new healthcare reality.
What makes this bookstand out from its competitors?
From the very beginningof brainstorming for this book, I knew it was essential to have conversationswith the industry's thought leaders, to find out how their organizations wereadapting to an increasingly technical field and where they saw things moving inthe future. More than 30 interviews later, we have stories from people likeChristoph Wald, chairman of the Department of Radiology at Lahey Hospital andMedical Center, who described how they used data analytics to take a hard lookat their department, from equipment utilization and radiation exposures totechnician and radiologist performance, reducing their imaging defect rate toless than 1%. I spoke to Kathryn Teng, Physician Executive Director atMetroHealth Medical Center who uses data analysis to research what theirpatient population needs and uses it to strategically determine where thehealth system should locate physician practices and how staffing shouldfluctuate to accommodate those needs. I spoke with Jeff Rice, CEO of HealthcareBluebook and Leah Binder, President and CEO of The Leapfrog Group about usingdata to help price and quality in healthcare become more transparent forpatients and employers. It's real-world examples like this, from across thehealthcare spectrum, that sets MoneyBall Medicine apart.
Is there a piece ofresearch or interview included in the book which surprised you or challengedyour previous understanding of this industry?
Despite decades workingin the industry, I am constantly surprised to see the resistance in healthcareto using data and technology. Take medical records--there are still doctors thatuse paper charts! That does a huge disservice to their patients who can'teasily view their own medical record, share that information with a differentdoctor--it keeps the utility of the data locked up.
Doctors are pulled in amillion directions and have less time with patients. They're expected to stayon top of the latest research, but it's nearly impossible with the number ofscientific studies being published every week. Standardizing patient care is adifficult sell, even when the data and studies suggest it gives patients betteroutcomes and can reduce healthcare costs. There's a big disconnect betweenpayer incentives and provider incentives and patients are caught in themiddle.
Disruption is messy.There's a lot of uncertainty in figuring out how technology like artificialintelligence and machine learning can best change the role of the pathologistand radiologist. Patients are feeling the financial squeeze of healthcare costsbut are unable to treat healthcare like other consumer goods and services. Iwas surprised just how much resistance to change there would be in healthcare,given the successes in other industries, but I think now we're on the cusp oftransformation--a true evolution of healthcare.
Finally, what did youenjoy most about writing the book?
Listeningto the experts describe how their companies are using Big Data and analytics totransform their work had to be the highlight. It's happening across every facetof the industry in very different ways. Some are patient-centric, others arefocused on health systems. How scientists are doing research is changing--wehave new models for clinical trials because of the power of data. Takingthese different threads and weaving them together while finding the businessangle in each story.
From the Back Cover:
"MoneyballMedicine discusses some of the remarkable innovations that are developingacross the healthcare industry. Harry and Malorye provide readers with a frontrow seat to the most important emerging healthcare system challenges - andopportunities - of our time. We started Flatiron because we wanted to ensurethat all cancer patients - not just those with the means and resources - haveaccess to the same cutting-edge research. It is our hope that this book willstimulate discussions around the value of next generation technology inhealthcare so that the industry can continue to innovate."
-Zach Weinberg, Co-founder, COO & President Flatiron Health
Thepolitical turbulence focused on what comes next for Medicaid, Medicare, and theACA (Obamacare) public exchange products simply reinforces the fundamentals ofhealth care in the United States. Increased access, increased value, and betterpatient experience will be keys for all successful stakeholders.In MoneyballMedicine, Harry and Malorye describe the unique confluence of entrepreneurialinnovation and the many entrenched and evolving health care components of thehealth care supply chain, and defines the parameters that predict who will winand who will lose.
-Glenn D.Steele, Jr., MD, PhD, Chairman of xG Health Solutions, Vice-Chair of HealthTransformation Alliance, and past CEO of Geisinger Health System
Theexplosive force that's transforming healthcare is digital. Harry and Maloyrehave aptly captured and described this tidal wave in a compelling compendium ofexamples and interviews. MoneyBall Medicine lays the foundation forunderstanding how new types of data will change the way we discover medicines,measure their impact, deploy, deliver and even replace them.
-Christine Lemke, Cofounder &President Evidation Health, Inc.
Howcan a smartwatch help patients with diabetes manage their disease? Why can'tpatients find out prices for surgeries and other procedures before they happen?How can researchers speed up the decade-long process of drug development? Howwill "Precision Medicine" impact patient care outside of cancer? What candoctors, hospitals, and health systems do to ensure they are maximizinghigh-value care? How can healthcare entrepreneurs find success in thisdata-driven market?
Arevolution is transforming the $10 trillion healthcare landscape, promisinggreater transparency, improved efficiency, and new ways of delivering care.This new landscape presents tremendous opportunity for those who are ready toembrace the data-driven reality. Having the right data and knowing how to useit will be the key to success in the healthcare market in the future. We arealready starting to see the impacts in drug development, precision medicine,and how patients with rare diseases are diagnosed and treated. Startups arelaunched every week to fill an unmet need and address the current problems inthe healthcare system. Digital devices and artificial intelligence are helpingdoctors do their jobs faster and with more accuracy.
MoneyBall Medicine: Thriving in the New Data-DrivenHealthcare Market, which includes interviews with dozens of healthcareleaders, describes the business challenges and opportunities arising for thoseworking in one of the most vibrant sectors of the world's economy. Doctors,hospital administrators, health information technology directors, andentrepreneurs need to adapt to the changes effecting healthcare today in orderto succeed in the new, cost-conscious and value-based environment of thefuture. The authors map out many of the changes taking place, describe how theyare impacting everyone from patients to researchers to insurers, and outlinesome predictions for the healthcare industry in the years to come.
"About this title" may belong to another edition of this title.